PLoS ONE (Jan 2016)

Correction: Baseline Serum Osteopontin Levels Predict the Clinical Effectiveness of Tocilizumab but Not Infliximab in Biologic-Naïve Patients with Rheumatoid Arthritis: A Single-Center Prospective Study at 1 Year (the Keio First-Bio Cohort Study).

  • Keisuke Izumi,
  • Yuko Kaneko,
  • Misato Hashizume,
  • Keiko Yoshimoto,
  • Tsutomu Takeuchi

DOI
https://doi.org/10.1371/journal.pone.0152341
Journal volume & issue
Vol. 11, no. 3
p. e0152341

Abstract

Read online

No abstracts available.